| Literature DB >> 28202388 |
Marc S Weinberg1, Hugh E Criswell2, Sara K Powell1, Aadra P Bhatt3, Thomas J McCown4.
Abstract
Recent advances suggest that in vivo reprogramming of endogenous cell populations provides a viable alternative for neuron replacement. Astrocytes and oligodendrocyte precursor cells can be induced to transdifferentiate into neurons in the CNS, but, in these instances, reprogramming requires either transgenic mice or retroviral-mediated gene expression. We developed a microRNA (miRNA)-GFP construct that in vitro significantly reduced the expression of polypyrimidine tract-binding protein, and, subsequently, we packaged this construct in a novel oligodendrocyte preferring adeno-associated virus vector. Ten days after rat striatal transduction, the vast majority of the GFP-positive cells were oligodendrocytes, but 6 weeks to 6 months later, the majority of GFP-positive cells exhibited neuronal morphology and co-localized with the neuronal marker NeuN. Patch-clamp studies on striatal slices established that the GFP-positive cells exhibited electrophysiological properties indicative of mature neurons, such as spontaneous action potentials and spontaneous inhibitory postsynaptic currents. Also, 3 months after striatal vector administration, GFP-positive terminals in the ipsilateral globus pallidus or substantia nigra retrogradely transported fluorescent beads back to GFP-positive striatal cell bodies, indicating the presence of functional presynaptic terminals. Thus, this viral vector approach provides a potential means to harness resident oligodendrocytes as an endogenous source for in vivo neuronal replacement.Entities:
Keywords: adeno-associated virus; gene therapy; neurons; oligodendrocytes; reprogramming; transdifferentiation
Mesh:
Substances:
Year: 2017 PMID: 28202388 PMCID: PMC5383550 DOI: 10.1016/j.ymthe.2017.01.016
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454